We are live on ! Find out more
NCCM

Nine Chapters Capital Management Portfolio holdings

AUM $45.4M
1-Year Est. Return 14.43%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+14.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$853M
AUM Growth
+$274M
Cap. Flow
+$257M
Cap. Flow %
30.11%
Top 10 Hldgs %
10.48%
Holding
1,056
New
443
Increased
160
Reduced
123
Closed
329

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$10.1M
2
CIT
CIT Group Inc.
CIT
+$10M
3
STZ icon
Constellation Brands
STZ
+$8.27M
4
AET
Aetna Inc
AET
+$7.67M
5
TIF
Tiffany & Co.
TIF
+$6.83M

Top Sells

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$7.22M
2
QCOM icon
Qualcomm
QCOM
+$6.38M
3
PSX icon
Phillips 66
PSX
+$6.06M
4
EBAY icon
eBay
EBAY
+$5.86M
5
BEN icon
Franklin Resources
BEN
+$5.45M

Sector Composition

Rank Sector Weight
1 Financials 14.95%
2 Industrials 14.86%
3 Technology 13.72%
4 Consumer Discretionary 10.87%
5 Healthcare 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSL
1001
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
– –
-18,600
Closed -$252K
CYBX
1002
DELISTED
CYBERONICS INC
CYBX
– –
-14,900
Closed -$774K
THOR
1003
DELISTED
THORATEC CORPORATION
THOR
– –
-16,500
Closed -$517K
RYL
1004
DELISTED
RYLAND GROUP INC
RYL
– –
-17,200
Closed -$690K
MRH
1005
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
– –
-8,400
Closed -$210K
ROSE
1006
DELISTED
ROSETTA RESOURCES INC
ROSE
– –
-13,800
Closed -$587K
GEVA
1007
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
– –
-6,400
Closed -$269K
PTP
1008
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
– –
-6,200
Closed -$355K
MWIV
1009
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
– –
-2,000
Closed -$246K
EPL
1010
DELISTED
EPL OIL & GAS, INC COMMON STK
EPL
– –
-37,900
Closed -$1.11M
XRTX
1011
DELISTED
XYRATEX LTD (BERMUDA)
XRTX
– –
-23,100
Closed -$232K
GIVN
1012
DELISTED
GIVEN IMAGING LTD
GIVN
– –
-14,700
Closed -$206K
CGX
1013
DELISTED
CONSOLIDATED GRAPHICS INC
CGX
– –
-4,600
Closed -$216K
NVE
1014
DELISTED
NV ENERGY, INC
NVE
– –
-18,200
Closed -$427K
KDN
1015
DELISTED
KAYDON CORP
KDN
– –
-14,200
Closed -$391K
ASTX
1016
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
– –
-10,300
Closed -$42K
MFB
1017
DELISTED
MAIDENFORM BRANDS, INC
MFB
– –
-13,600
Closed -$236K
ARB
1018
DELISTED
ARBITRON INC (NEW)
ARB
– –
-10,000
Closed -$465K
ASCA
1019
DELISTED
AMERISTAR CASINOS INC
ASCA
– –
-8,600
Closed -$226K
ET
1020
DELISTED
EXACTTARGET INC COM STK (DE)
ET
– –
-20,500
Closed -$691K
EOX
1021
DELISTED
EMERALD OIL INC (MT)
EOX
– –
-1,135
Closed -$156K
CTIC
1022
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-1,730
Closed -$18K
RXII
1023
DELISTED
GALENA BIOPHARMA INC COM
RXII
– –
-23,900
Closed -$53K
RAS
1024
DELISTED
RAIT Financial Trust
RAS
– –
-29,100
Closed -$219K
XL
1025
DELISTED
XL Group Ltd.
XL
– –
-59,400
Closed -$1.8M
39 40
41
42 43

Similar funds

CZPM
Capital Z Partners Management New York $47.4M AUM 35.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
DAC
Dymon Asia Capital Singapore $48.4M AUM 73.84% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
PCP
Proprium Capital Partners Stamford, Connecticut $54M AUM 7.85% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return

Nine Chapters Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Nine Chapters Capital Management held 1,056 positions worth $853M, up 47% from $578M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Nine Chapters Capital Management deployed $257M of net new capital in Q3 2013, opening 443 new positions and adding to 160 existing holdings. Its largest new stake was Northrop Grumman: 109,700 shares worth $10.4M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Eli Lilly, an estimated $5.08M trimmed.

  • Nine Chapters Capital Management's largest Q3 2013 buy was Northrop Grumman: 109,700 shares worth $10.4M.
  • Nine Chapters Capital Management added most to Aetna Inc in Q3 2013, an estimated $7.67M increase.
  • Nine Chapters Capital Management's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $5.08M.
  • Nine Chapters Capital Management fully exited Travelers Companies in Q3 2013, selling an estimated $7.22M.
  • Nine Chapters Capital Management's ten largest holdings make up 10% of its $853M portfolio in Q3 2013.
  • Nine Chapters Capital Management opened 443 new positions and closed 329 in Q3 2013.
  • Nine Chapters Capital Management's portfolio value rose 47% quarter-over-quarter to $853M.

Based on Nine Chapters Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.